ACADIA Pharmaceuticals
ACAD
#3888
Rank
S$4.36 B
Marketcap
S$25.51
Share price
0.30%
Change (1 day)
-7.39%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2026 (TTM): S$0.15 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are S$1.13 Billion. In 2025 the company made an earning of S$0.17 Billion a decrease over its 2024 earnings that were of S$0.33 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.15 B-11.86%
2025 S$0.17 B-46.18%
2024 S$0.33 B-605.67%
2023 -S$65.27 Million-76.09%
2022 -S$0.28 Billion27.41%
2021 -S$0.22 Billion-40.38%
2020 -S$0.36 Billion19.88%
2019 -S$0.3 Billion-3.92%
2018 -S$0.32 Billion-15.04%
2017 -S$0.37 Billion6.33%
2016 -S$0.35 Billion64.55%
2015 -S$0.21 Billion77.47%
2014 -S$0.12 Billion143.69%
2013 -S$48.54 Million81.93%
2012 -S$26.68 Million-8.73%
2011 -S$29.23 Million-251.39%
2010 S$19.3 M-133.2%
2009 -S$58.16 Million-30.82%
2008 -S$84.06 Million6.43%
2007 -S$78.98 Million25.89%
2006 -S$62.74 Million36.99%
2005 -S$45.8 Million37.22%
2004 -S$33.38 Million19.96%
2003 -S$27.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.51 B 21,493.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$8.83 B 5,590.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$42.96 B 27,580.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$15.23 B 9,713.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-S$0.24 Billion-252.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-S$49.41 Million-131.83%๐Ÿ‡บ๐Ÿ‡ธ USA